Predicting Drug Absorption: How Nature Made It a Difficult Problem

Significant recent work has focused on predicting drug absorption from structure. Several misperceptions regarding the nature of absorption seem to be common. Among these is that intestinal absorption, permeability, fraction absorbed, and, in some cases, even bioavailability, are equivalent properties and can be used interchangeably. A second common misperception is that absorption, permeability, etc. are discrete, fundamental properties of the molecule and can be predicted solely from some structural representation of the drug. In reality, drug absorption is a complex process dependent upon drug properties such as solubility and permeability, formulation factors, and physiological variables, including regional permeability differences, pH, lumenal and mucosal enzymology, and intestinal motility, among others. This article will explore the influence of these different variables on drug absorption and the implications with regards to attempting to develop predictive drug absorption algorithms.

[1]  A. Seelig.  A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.

[2]  Yi Wang,et al.  Chapter 27. Ex vivo approaches to predicting oral pharmacokinetics in humans , 2000 .

[3]  G. Kottra,et al.  Functional properties of the paracellular pathway in some leaky epithelia. , 1983, The Journal of experimental biology.

[4]  H Lennernäs,et al.  Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.

[5]  W. L. Chiou,et al.  An alternative hypothesis to involvement of intestinal P-glycoprotein as the cause for digoxin oral bioavailability enhancement by talinolol. , 2001, Clinical pharmacology and therapeutics.

[6]  A. N. Jain,et al.  Molecular hashkeys: a novel method for molecular characterization and its application for predicting important pharmaceutical properties of molecules. , 1999, Journal of medicinal chemistry.

[7]  U Norinder,et al.  Theoretical calculation and prediction of drug transport processes using simple parameters and partial least squares projections to latent structures (PLS) statistics. The use of electrotopological state indices. , 2001, Journal of pharmaceutical sciences.

[8]  J J Baldwin,et al.  Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.

[9]  U Norinder,et al.  Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.

[10]  Diamond Jm,et al.  Twenty-first Bowditch lecture. The epithelial junction: bridge, gate, and fence. , 1977 .

[11]  I. Wilding,et al.  Site-specific drug delivery in the gastrointestinal tract. , 2000, Critical reviews in therapeutic drug carrier systems.

[12]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[13]  Thomas J. Raub,et al.  Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. , 1995, Journal of pharmaceutical sciences.

[14]  I. Tamai,et al.  Carrier-mediated approaches for oral drug delivery , 1996 .

[15]  Hans Lennernäs,et al.  Jejunal Absorption and Metabolism of R/S-Verapamil in Humans , 1998, Pharmaceutical Research.

[16]  I. Wilding,et al.  The effect of mannitol on the oral bioavailability of cimetidine. , 1995, Journal of pharmaceutical sciences.

[17]  B. Gumbiner,et al.  Structure, biochemistry, and assembly of epithelial tight junctions. , 1987, The American journal of physiology.

[18]  D. Fleisher,et al.  Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration , 1999, Clinical pharmacokinetics.

[19]  Shiew-Mei Huang,et al.  Effect of St John's wort on the pharmacokinetics of fexofenadine , 2002, Clinical pharmacology and therapeutics.

[20]  Joe Palandra,et al.  Predicting Oral Absorption of Drugs: A Case Study with a Novel Class of Antimicrobial Agents , 2003, Pharmaceutical Research.

[21]  G. Amidon,et al.  Intestinal metabolism promotes regional differences in apical uptake of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability in rat. , 2002, The Journal of pharmacology and experimental therapeutics.

[22]  S. Pond,et al.  First-Pass Elimination Basic Concepts and Clinical Consequences , 1984, Clinical pharmacokinetics.

[23]  D. Shen,et al.  Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. , 1997, The Journal of pharmacology and experimental therapeutics.

[24]  Kevin C. Johnson,et al.  Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption , 1996, Pharmaceutical Research.

[25]  G Beck,et al.  Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.

[26]  Peter C. Jurs,et al.  Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..

[27]  W. Higuchi,et al.  Advancing quantitative and mechanistic approaches in interfacing gastrointestinal drug absorption studies in animals and humans , 1983 .

[28]  A. Parr,et al.  Effect of Sodium Acid Pyrophosphate on Ranitidine Bioavailability and Gastrointestinal Transit Time , 1993, Pharmaceutical Research.

[29]  Lawrence X. Yu,et al.  Predicting Human Oral Bioavailability of a Compound: Development of a Novel Quantitative Structure-Bioavailability Relationship , 2000, Pharmaceutical Research.

[30]  P. Swaan,et al.  Molecular mechanism for the relative binding affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril. , 1995, Biochimica et biophysica acta.

[31]  Patrick J. Sinko,et al.  Predicting Fraction Dose Absorbed in Humans Using a Macroscopic Mass Balance Approach , 1991, Pharmaceutical Research.

[32]  J. Dressman,et al.  Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.

[33]  K. Brouwer,et al.  Pharmacokinetic and Pharmacodynamic Implications of P‐glycoprotein Modulation , 2001, Pharmacotherapy.

[34]  J. Diamond.  Twenty-first Bowditch lecture. The epithelial junction: bridge, gate, and fence. , 1977, The Physiologist.

[35]  R. E. White,et al.  High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery. , 2000, Annual review of pharmacology and toxicology.

[36]  C. Beglinger,et al.  Relevance of p‐glycoprotein for the enteral absorption of cyclosporin A: in vitro‐in vivo correlation , 1996, British journal of pharmacology.

[37]  J. Bennett,et al.  Diet-controlled blood levels of oltipraz in healthy male subjects. , 1984, The Journal of antimicrobial chemotherapy.

[38]  N. Kaniwa,et al.  Gastric acidity dependent bioavailability of cinnarizine from two commercial capsules in healthy volunteers , 1986 .

[39]  Terry R Stouch,et al.  Progress in understanding the structure-activity relationships of P-glycoprotein. , 2002, Advanced drug delivery reviews.

[40]  D. E. Clark.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.

[41]  L. Benet,et al.  Active secretion and enterocytic drug metabolism barriers to drug absorption. , 2001, Advanced drug delivery reviews.

[42]  Vinod P. Shah,et al.  Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions , 2002, Pharmaceutical Research.

[43]  G Folkers,et al.  Review of theoretical passive drug absorption models: historical background, recent developments and limitations. , 1996, Pharmaceutica acta Helvetiae.

[44]  Akira Tsuji,et al.  Carrier-Mediated Intestinal Transport of Drugs , 1996, Pharmaceutical Research.

[45]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[46]  G. Liversidge,et al.  Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs , 1995 .

[47]  J. Dietschy,et al.  Delineation of the dimensions and permeability characteristics of the two major diffusion barriers to passive mucosal uptake in the rabbit intestine. , 1974, The Journal of clinical investigation.